Global X Aging Population ETF Rating $33.30 +0.06 (+0.18%) Closing price 03:58 PM EasternExtended Trading$33.30 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Aging Population ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.AGNG Aggregate RatingModerate Buy 2.73Holdings in AGNG have an aggregate rating of Moderate Buy based on 305 analyst ratings issued in the past year covering 16 companies (44.7% of the portfolio).AGNG Aggregate Price Target$33.30High Prediction$33.30Average Prediction$33.30Low Prediction$33.30Holdings in AGNG have an aggregate price target of $33.30 and a range of $33.30 to $33.30 covering 16 companies (44.7% of the portfolio).AGNG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Aging Population ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 16 AGNG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.19%AZNAstraZeneca$79.93-0.1%2.7717 of 5 stars2.80$86.00 7.6%5Positive News3.13%WELLWelltower$167.95+1.3%4.1306 of 5 stars2.80$174.10 3.7%10Positive NewsAnalyst Forecast3.08%ABBVAbbVie$208.24-0.1%4.7028 of 5 stars2.96$214.95 3.2%27Trending NewsAnalyst Forecast3.08%EWEdwards Lifesciences$81.01-0.3%4.4819 of 5 stars2.65$85.90 6.0%26Positive News3.08%JNJJohnson & Johnson$176.69+0.1%4.8774 of 5 stars2.65$176.29 -0.2%20Positive NewsOptions Volume3.04%BSXBoston Scientific$105.94-0.4%4.7191 of 5 stars3.04$117.50 10.9%26Positive News2.97%MDTMedtronic$91.98-0.2%4.9658 of 5 stars2.63$102.14 11.1%19Analyst ForecastInsider Trade2.96%SYKStryker$393.37-0.2%4.4467 of 5 stars2.79$430.10 9.3%19Positive News2.77%MRKMerck & Co., Inc.$84.16-1.0%4.9978 of 5 stars2.35$107.44 27.7%20Positive News2.74%AMGNAmgen$287.97-0.6%4.7436 of 5 stars2.33$304.43 5.7%21Positive NewsAnalyst Forecast2.68%REGNRegeneron Pharmaceuticals$586.96-0.1%4.8566 of 5 stars2.81$817.67 39.3%27Trending NewsAnalyst Forecast2.49%LLYEli Lilly and Company$734.54-0.2%4.9993 of 5 stars2.70$950.17 29.4%23Trending NewsAnalyst Upgrade2.42%DXCMDexCom$76.38+0.3%4.9621 of 5 stars2.95$99.89 30.8%22Positive News2.38%BMYBristol Myers Squibb$47.60+0.8%4.7355 of 5 stars2.24$56.38 18.4%212.36%ONCBeOne Medicines$300.14-2.8%1.413 of 5 stars3.00$330.89 10.2%72.28%VTRVentas$67.90+0.4%4.1238 of 5 stars2.92$74.18 9.2%12Positive NewsAnalyst Forecast This page (NASDAQ:AGNG) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Aging Population ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Aging Population ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access